Evidence map›Paper›PMID 25053982›Full record

ReviewThe Journal of clinical and aesthetic dermatology2014

Beta blockers: an innovation in the treatment of infantile hemangiomas.

Shehla Admani, Stephanie Feldstein, Ernesto M Gonzalez, Sheila Fallon Friedlander

Open access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in The Journal of clinical and aesthetic dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Oral Beta-blocker in Problematic Infantile Hemangioma.Plastic and reconstructive surgery. Global open · 2021
    Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shehla AdmaniDivision of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
Stephanie FeldsteinDivision of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
Ernesto M GonzalezDepartment of Pediatrics, University of Chicago, Chicago, Illinois.
Sheila Fallon FriedlanderDivision of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
Rady Children's Hospital-San Diego · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infantile hemangiomas are benign vascular tumors seen in 4.5 percent of neonates and infants. While most infantile hemangiomas can be managed with active nonintervention, a subset of patients will require more aggressive management. Here the authors review the use of beta-blockers in the treatment of infantile hemangiomas, including oral, topical, and multimodal treatment options. They discuss the latest data on propranolol, including criteria for patient selection, dosing recommendations, and appropriate monitoring for side effects and efficacy. Lastly, they review indications for topical timolol treatment and the potential benefits of concomitant laser therapy.

Identifiers

PMID25053982
PMCPMC4106356
OpenAlexW47907695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.